Table 2 Model parameters for PFS and OS.
From: Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma
Parameter (standard error) | ||
|---|---|---|
Log-normal survival model | ||
PFS of Eribulin regimen | meanlog = 1.6202 (0.1166) | sdlog = 0.9195 (0.0864) |
PFS of Dacarbazine regimen | meanlog = 1.3343 (0.0755) | sdlog = 0.8583 (0.0562) |
OS of Eribulin regimen | meanlog = 2.929 (0.132) | sdlog = 1.023 (0.106) |
OS of Dacarbazine regimen | meanlog = 2.6304 (0.0887) | sdlog = 1.0054 (0.0688) |
